Tong Ren Tang

Digital Health on a Rise: JD Health Stocks Spike 70% on First Trading Day

The company is the third online healthcare platform listed on the Hong Kong bourse, also the third 'JD family' member to be listed in 2020.

Ding Dang Kuai Yao: A Chinese E-Commercial Way to Run a Pharmacy

Are offline pharmacies still your preferred way to buy medicine? Many Chinese can get urgent drugs delivered to their door via WeChat. Ding Dang Kuai Yao’s CNY 1 billion Series B further is further proving the efficacy of this business.

Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020

In the times of crisis like COVID-19, even established companies risk falling due to the sudden drop in their income. By contrast, companies that cling to innovation may unlock more value as they fight against the challenges.

China Speed: Two COVID-19 Vaccines Recognized by WHO

As the second blow of the pandemic comes near the sight, China's newly-developed vaccines have been approved by the World Health Organization and available at an affordable price.

SoYoung, First Internet Medical Cosmetology Stock on Nasdaq: Not Easy to Move Forward

The hundreds of billions-level market potential of the Chinese medical cosmetology economy has attracted Meituan Dianping, Ali Health and JD Health to take a share. SoYoung, a beauty tips provider, is facing a more challenging situation than mere slumped business amid the COVID-19 quarantine.

Ali Health Aims Higher with Rebranding and New Strategies

This month, Ali Health renamed its healthcare app 'Yi Lu' and adopted a cartoon image – a deer doctor. A Chinese play on words yields a secondary meaning along the lines of ‘well-being along the way.' More than this, though, the profile change is a signpost for a significant strategy upgrade.​​​​​​​

After China's BNR and GTH Hit Nasdaq, Pan-Cancer Detector GRAIL Eyes IPO

The early-stage cancer-detection technology has declared its mission: to take on and defeat the fatal illness, for the benefit of humanity. Following Burning Rock and Genetron Health, the US biotech GRAIL looks to go public on Nasdaq.

Bid for Molecular Tech in China's Early-Stage Cancer Detection Market

China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role. 

More Room for the Medical Device Market to Grow in China

The medical device market in China is substantial – it also has massive niche markets. The domestic market size growth has surpassed that of the global market for many years, showing strong potential for development.

Backed up by Rich Dad – What’s Next for Ping An Good Doctor?

Having a rich dad can help with capital and connections when a company is at the ‘infant’ stage. But being independent comes sooner or later. When shall that be for Ping An Good Doctor? Or will it not come at all?

AI Is Transforming China's Healthcare Industry

As AI gets more advanced, it is injecting vitality into traditional industries, allowing participants to picture very different futures to what they envisioned before.      

Alibaba, Tencent and Ping An Group: A Healthcare Update

All digitized and refurbished health services continue to swell, how are these streamlined competitors getting along?

Tong Ren Tang: Any Hope for this Purveyor of Centuries-Old Chinese Medicines?

Since the biotechnology pharmaceutical scene has become a red ocean, attracting new entrants and capital, TCM players are encountering some harsh new realities.

Chinese CT Big Brother Neusoft Eyes the Booming Star Market

Chinese Nasdaq-like market, Star Market, is attracting another healthcare company. Neusoft Medical is looking forward to an IPO fundraising for tomography development.

Good Practice | Key Takeaways from Webinar 'AI in China: 2020 and Beyond'

EqualOcean held an online event on June 30. Here is what 500 Startups' Stella Zheng and Zhuiyi Technology's Terry Ke think about the pandemic and AI.

Modern Chinese Medicine Maker Tasly Pharmaceutical: An Old Stock in a New Package?

Tasly Pharmaceutical, founded in 1994 and listed on SSE in 2002, is valued at CNY 26.9 billion – a market cap that the company once achieved ten years ago. But did the company merely spin in circles during the last decade?

Top 10 Market Cap Chinese Medical Device Companies: Champions and Runners-Up

In a recent boom in the Chinese A-share market, the medical device segment has shown a surprising performance, proving its investability and growth potential.

COVID-19 and AI | Key Takeaways from Webinar 'AI in China: 2020 and Beyond'

EqualOcean held an online event on June 30. Here is what 500 Startups' Stella Zheng and Zhuiyi Technology's Terry Ke think about the pandemic and AI.

YuYue Medical Devices: Not Too Late to Focus on R&D

Running a pool of over 1.13 million fans on its Tmall online shop, Jiangsu YuYue stands out from its peer group, with over 53.3 thousand sales of its hit sphygmomanometer product within the last month.

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.